These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8124743)

  • 21. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D; Karavani G; Hirsch HJ; Strich D
    J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term therapy with delayed-action LHRH-antagonist decapeptyl depot in girls with precocious puberty. Results of an international multicenter study].
    Sippell WG; Partsch CJ; Hümmelink R; Lorenzen F
    Gynakologe; 1991 Apr; 24(2):108-13. PubMed ID: 1835952
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty.
    Arrigo T; Cisternino M; Galluzzi F; Bertelloni S; Pasquino AM; Antoniazzi F; Borrelli P; Crisafulli G; Wasniewska M; De Luca F
    Eur J Endocrinol; 1999 Aug; 141(2):140-4. PubMed ID: 10427157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of treatment on growth in children with central precocious puberty].
    Snajderová M; Zemková D; Lebl J; Kolousková S
    Cas Lek Cesk; 1995 Mar; 134(6):173-5. PubMed ID: 7758068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in growth hormone-binding protein in girls with central precocious puberty treated with a depot preparation of luteinizing hormone-releasing hormone analogue.
    Oliveira SB; Donnadieu M; Chaussain JL
    Horm Res; 1993; 39(1-2):42-6. PubMed ID: 8406338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth].
    Hofmann-Ehrhart B; Schulz U; Kluge M; Wandl-Vergesslich K; Waldhauser F
    Wien Klin Wochenschr; 1995; 107(14):413-7. PubMed ID: 7668000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The significance and characteristics of the LHRH test in diagnosing precocious puberty development in girls: the stimulated LH/FSH quotient differentiates between central precocious puberty and premature thelarche].
    Partsch CJ; Hümmelink R; Lorenzen F; Sippell WG
    Monatsschr Kinderheilkd; 1989 May; 137(5):284-8. PubMed ID: 2525665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
    Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog].
    Snajderová M; Lebl J; Zemková D; Kolousková S; Pechová M
    Cesk Pediatr; 1994; 49(1):25-8. PubMed ID: 8124746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Estradiol Response after Depot Triptorelin Administration in Girls with Central Precocious Puberty.
    Freire AV; Gryngarten MG; Ballerini MG; Arcari AJ; Escobar ME; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2016; 85(1):58-64. PubMed ID: 26675317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A; Sharma J; Kabra M; Gupta AK; Menon PS
    Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
    Lahlou N; Roger M; Chaussain JL; Feinstein MC; Sultan C; Toublanc JE; Schally AV; Scholler R
    J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Improvement of expected and final height in girls with central precocious puberty treated with gonadotropin releasing hormone analogues].
    Gómez F; Picó AM; Vargas F; Mauri M
    Med Clin (Barc); 1996 Nov; 107(18):681-4. PubMed ID: 9082075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
    Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Short-term comparison of the treatment of precocious puberty with 2 different LHRH antagonists (buserelin and long-acting triptorelin). An endocrinologic and echographic study].
    Cicognani A; Cacciari E; Balsamo A; Cassio A; Papasodero A; Bellizzi M; Guacci P; Zappulla F
    Pediatr Med Chir; 1994; 16(1):43-8. PubMed ID: 8029088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.